AnaBioTec offers end-to-end analytical drug development solutions supporting CMC activities for pharmaceutical and biotech companies. Our analytical services are available for Small Molecules, Biologics, Cell & Gene Therapy products during preclinical, clinical study phases and commercial lifecycle. With more than 25 years of experience in analytical method development and validation we help you mitigating risk and accelerating timelines. Our experienced scientific project managers connect the dots in your projects and anticipate were needed and safeguard your milestones.
| Website | http://www.anabiotec.com |
| Revenue | $15 million |
| Employees | 78 (55 on RocketReach) |
| Founded | 1999 |
| Industry | Pharmaceutical Manufacturing |
| Web Rank | 12 Million |
| Keywords | Pharmaceutical Development, Drug Development Services, Pharmaceutical Analysis, End To End Solutions, Process Analytical Technology, Biopharmaceutical Analysis, Small Molecule Analysis, Biotech Solutions, Analytical Chemistry, Cell And Gene Therapy, Analytical Testing, Drug Product Testing, Preclinical Testing, Clinical Trial Materials, Quality Control Testing, Regulatory Support |
| Competitors | Amgen, Regeneron, DuPont, Novozymes, Twist Bioscience, Codexis, Inc., Geno, Zymergen, Inc., Calyxt, TetraVitae Biosciences +38 more (view full list) |
Looking for a particular AnaBioTec employee's phone or email?
AnaBioTec Questions
The AnaBioTec annual revenue was $15 million in 2026.
Herman Nuytten is the CSO of AnaBioTec.
55 people are employed at AnaBioTec.
Top AnaBioTec Employees
-
Herman Nuytten
CSO at AnaBioTec
Ghent, BE33 -
1
-
Lie Wauters
Senior manager operations at AnaBioTec
Flanders, Belgium2
Related Companies
